Agriculture products company SiteOne Landscape Supply (NYSE:SITE) met Wall Street’s revenue expectations in Q2 CY2025, with ...

Q2 2025 Management View Doug Black, Chairman and CEO, stated that "we are pleased to achieve continued solid results during ...

Shares of SiteOne Landscape Supply (NYSE:SITE) jumped as much as 11% on Wednesday to their highest level since mid-February, ...

SiteOne Landscape (SITE) delivered earnings and revenue surprises of -1.04% and -0.06%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Despite the miss, SiteOne improved its profitability metrics, with Adjusted EBITDA increasing 8% to $226.7 million and Adjusted EBITDA margin expanding by 60 basis points to 15.5%. Gross profit rose 4 ...

ROSWELL, Ga. (AP) — ROSWELL, Ga. (AP) — SiteOne Landscape Supply, Inc. (SITE) on Wednesday reported second-quarter profit of $129 million. The Roswell, Georgia-based company said it had net income of ...

SiteOne Landscape Supply, Inc., together with its subsidiaries, engages in the wholesale distribution of landscape supplies in the United States and Canada. The company provides irrigation ...

SiteOne Landscape Supply, Inc. (NYSE: SITE), is the largest and only national full product line wholesale distributor of landscape supplies in the United States and has a growing presence in Canada.

SiteOne Landscape Supply is hosting the 27th Women In the Green Industry conference in Las Vegas from September 10-12 at ...

Eli Lilly will buy privately held SiteOne Therapeutics in a deal worth as much as $1 billion, the companies said on Tuesday, giving the drugmaker access to an experimental non-opioid pain medicine.

SiteOne Therapeutics is a biopharmaceutical company advancing a novel class of highly selective small molecule inhibitors targeting Na V 1.7, Na V 1.8, and other voltage-gated ion channels to ...

SiteOne’s drug candidate, STC-004, is on track to begin Phase 2 testing. SiteOne develops drugs that target sodium channels, which are found primarily in the peripheral nervous system.